Rapamycin and IL-2 Prevents Lethal Acute Graft-Versus Host Disease by Expansion of Donor Type CD4+CD25+Foxp3+ Regulatory T Cells.

被引：0
|
作者：
Shin, Ho-Jin [1 ]
Baker, Jeanette [1 ]
Leveson-Gower, Dennis [1 ]
Sega, Emanuela I. [1 ]
Negrin, Robert [1 ]
机构：
[1] Stanford Univ, Dept Med, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：545 / 545
页数：1
相关论文
共 50 条
  • [31] The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells
    Shevach, Ethan M.
    DiPaolo, Richard A.
    Andersson, John
    Zhao, Dong-Mei
    Stephens, Geoffrey L.
    Thornton, Angela M.
    IMMUNOLOGICAL REVIEWS, 2006, 212 : 60 - 73
  • [32] NAD+ Promotes Allograft Survival Independently of CD4+CD25+Foxp3+ Regulatory T Cells.
    Elkhal, A.
    Biefer, H. Rodriguez Cetina
    Uehara, H.
    Quante, M.
    Seyda, M.
    Schuitenmaker, J.
    Tullius, S.
    Elkhal, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 293 - 293
  • [33] Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation
    Hoffmann, P
    Ermann, J
    Edinger, M
    Fathman, CG
    Strober, S
    JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03): : 389 - 399
  • [34] CD4+CD25+ regulatory T cells and graft-versus-host disease
    Hoffmann, P
    Edinger, M
    SEMINARS IN HEMATOLOGY, 2006, 43 (01) : 62 - 69
  • [35] Chronic graft-versus-host disease correlates with reduced frequency of FOXP3+CD4+CD25+regulatory T cells
    Zorn, E
    Kim, HT
    Lee, SJ
    Floyd, BH
    Litsa, D
    Arumugarajah, S
    Bellucci, R
    Antin, JH
    Soiffer, RJ
    Ritz, J
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 47 - 48
  • [36] Pretreatment of Rapamycin Before Allogenic Corneal Transplant Promotes Graft Survival Through Increasing CD4+CD25+Foxp3+ Regulatory T Cells
    Wang, Xin
    Wang, Wentao
    Xu, Jianjiang
    Hong, Jiaxu
    Le, Qihua
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2013, 11 (01) : 56 - 62
  • [37] Rapamycin combined with allogenic immature dendritic cells selectively expands CD4+CD25+Foxp3+ regulatory T cells in rats
    Wang, Guo-Ying
    Zhang, Qi
    Yang, Yang
    Chen, Wen-Jie
    Liu, Wei
    Jiang, Nan
    Chen, Gui-Hua
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2012, 11 (02) : 203 - 208
  • [38] Induction of transplantation tolerance by allogeneic donor-derived CD4+CD25+Foxp3+ regulatory T cells
    Velasquez-Lopera, Margarita M.
    Eaton, Valerie L.
    Lerret, Nadine M.
    Correa, Luis A.
    DeCresce, Robert P.
    Garcia, Luis F.
    Jaramillo, Andres
    HUMAN IMMUNOLOGY, 2007, 68 : S74 - S74
  • [39] Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients
    Segundo, David San
    Ruiz, Juan Carlos
    Izquierdo, Maria
    Fernandez-Fresnedo, Gema
    Gomez-Alamillo, Carlos
    Merino, Ramon
    Benito, Maria Jesus
    Cacho, Eva
    Rodrigo, Emilio
    Palomar, Rosa
    Lopez-Hoyos, Marcos
    Arias, Manuel
    TRANSPLANTATION, 2006, 82 (04) : 550 - 557
  • [40] Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells
    Zeiser, Robert
    Leveson-Gower, Dennis B.
    Zambricki, Elizabeth A.
    Kambham, Neeraja
    Beilhack, Andreas
    Loh, John
    Hou, Jing-Zhou
    Negrin, Robert S.
    BLOOD, 2008, 111 (01) : 453 - 462
12345